The experimental design was deliberately rigorous. The team infected 7-to-10-week-old and 12-month-old female and male Syrian golden hamsters intranasally with the BavPat1/2020 SARS-CoV-2 isolate, then followed them for five days under biosafety level 3 conditions. Crucially, the researchers paired classic disease readouts with a comprehensive lipidomic analysis: they quantified viral RNA in oropharyngeal swabs, bronchoalveolar lavage fluid, lung, duodenum, and colon by real-time reverse transcription PCR, scored pulmonary lesions histopathologically, and measured cholesterol and six distinct oxysterol species by high-performance liquid chromatography in intestinal tissues, lung, and serum. The lipid measurements were performed after methanol-mediated viral inactivation, validated with spiking experiments, so that samples could safely leave the high-containment laboratory for analysis.

Clinically, the model reproduced what is now well established for aged hamsters. From day three post infection onward, the older animals deteriorated markedly: by day five their mean clinical score reached 6.5 points, compared with 3.7 points in young animals whose condition had stabilized, and aged hamsters lost the most weight relative to their starting body mass. Hypersalivation, particularly pronounced in aged females, was an additional distinctive sign. Yet when the pathologists examined the lungs, the picture was surprisingly uniform. Total lesion scores, comprising alveolar, airway, and vascular changes, rose significantly in all infected groups but did not differ between age groups, and mild rhinitis and tracheitis appeared across the board. The aged animals were sicker without having visibly worse lungs.

The intestine told a different story. Although microscopic examination of the duodenum and colon revealed no overt tissue damage or SARS-CoV-2 nucleoprotein immunoreactivity in either age group, molecular testing showed that aged hamsters carried significantly higher SARS-CoV-2 RNA loads in both intestinal segments than their young counterparts. Respiratory viral RNA in swabs and lavage fluid was also slightly higher in the aged groups. This combination, a morphologically silent but virologically active gut infection concentrated in older hosts, positioned the intestine as a key site where age-dependent differences in viral burden and metabolic response could be dissected without the confounding noise of severe tissue pathology.

The lipidomic data revealed a stark divergence. Upon infection, young hamsters showed a striking upregulation of the side-chain oxysterols 25-hydroxycholesterol and 27-hydroxycholesterol in duodenum and colon, and this pattern was mirrored in serum, where both molecules rose significantly. These compounds are not passive metabolic byproducts. 25-hydroxycholesterol in particular is recognized as a central component of innate antiviral defense, capable of blocking viral fusion and replication, suppressing inflammasome activation through liver X receptor–dependent inhibition of sterol regulatory element-binding protein signaling, and participating in interferon-mediated immune regulation. In aged hamsters, this protective response was essentially absent: intestinal 27-hydroxycholesterol was mostly undetectable even after infection, and the modest rise in 25-hydroxycholesterol never reached statistical significance in any tissue.

Instead, the aged animals showed a selective accumulation of ring oxysterols, oxidized at the sterol ring rather than the side chain. Colonic 4β-hydroxycholesterol surged in infected aged hamsters and correlated strongly and positively with clinical score, age, and viral RNA loads in both bronchoalveolar lavage fluid and oral swabs, while showing negative correlations with serum cholesterol and the protective side-chain oxysterols. This finding echoes earlier reports that 4β-hydroxycholesterol rises in colitis in humans and mouse models, hinting at a role in colonic inflammation. Meanwhile 7β-hydroxycholesterol, another ring oxysterol, was significantly downregulated in the intestines of infected aged animals, whereas 7-ketocholesterol and 5β,6β-epoxycholesterol remained unchanged, indicating a selective remodeling of specific oxysterol pathways rather than a blanket increase in oxidative cholesterol products.

A plausible mechanism for this age-dependent shift lies in the biology of aging itself. Advancing age is associated with mitochondrial dysfunction and elevated production of reactive oxygen species, which drive nonenzymatic autooxidation of cholesterol into ring oxysterols, a hallmark of age-related oxidative stress frequently observed in tissues of elderly individuals with inflammatory comorbidities. Side-chain oxysterols, by contrast, are generated enzymatically, and their coordinated induction in young animals reflects a targeted metabolic defense. Notably, oxysterols were undetectable in lung tissue regardless of age or infection status, yet young hamsters showed a significant depletion of lung cholesterol after infection while aged animals showed only a nonsignificant trend, suggesting that the pulmonary response to SARS-CoV-2 operates through cholesterol depletion rather than local oxysterol production.

The correlation analyses tied these threads into a coherent, if still correlative, framework. Intestinal and serum side-chain oxysterols were positively correlated with each other, supporting the intestine as a major source of circulating oxysterols, and both showed significant negative correlations with viral RNA in bronchoalveolar lavage fluid and with clinical severity. Serum 25-hydroxycholesterol inversely correlated with age. Perhaps most strikingly, side-chain oxysterols from the duodenum and colon, and serum 25-hydroxycholesterol, all correlated negatively with total lung cholesterol, which itself was inversely associated with viral load and clinical score. Because SARS-CoV-2 entry depends on cholesterol-rich lipid rafts that anchor the ACE2 receptor, reduced cholesterol availability in pulmonary cells could plausibly restrict viral entry, offering a mechanistic rationale for how gut-derived oxysterols might protect the lung from a distance.

The study also uncovered systemic signatures with practical potential. Because oxysterol measurement is not routine in clinical settings, the team searched for surrogates among standard blood chemistry parameters. Serum 25-hydroxycholesterol correlated positively with total bilirubin and negatively with total protein and globulin, markers that were themselves linked to advanced age and more severe disease, while declining potassium, inorganic phosphate, and creatine phosphokinase tracked with better outcomes and younger age. The drop in potassium and phosphate in aged hamsters alongside higher intestinal viral loads hints at an infection-induced malabsorptive phenotype, possibly involving a shift of the epithelium toward goblet cell hyperplasia at the expense of absorptive enterocytes, a remodeling described in other coronaviruses through disruption of Notch signaling. The authors are appropriately cautious: elevated 25-hydroxycholesterol may reflect an effective host response rather than cause it, and distinguishing these possibilities will require targeted mechanistic studies. They also propose that antioxidant nutritherapeutics, such as alpha-tocopherol and polyphenols, which counteract ring oxysterol toxicity, could merit exploration as a strategy to improve outcomes in elderly patients, pending validation in larger cohorts and clinical trials.

Subject of Research: Age-dependent intestinal oxysterol remodeling during SARS-CoV-2 infection in Syrian hamsters

Article Title: Intestinal oxysterol remodeling underlies severe COVID-19 in an aged hamster model

Article References: Mergani, A., Wirz, K., Reineking, W., Richter, A., Lechler, V., Pilchová, V., Störk, T., Michaely, L. M., Zdora, I., Buettner, M., Volz, A., Bleich, A., Baumgärtner, W., Schulz, C., & von Köckritz-Blickwede, M. (2026). Intestinal oxysterol remodeling underlies severe COVID-19 in an aged hamster model. GeroScience. https://doi.org/10.1007/s11357-026-02531-1

Image Credits: AI Generated

DOI: 10.1007/s11357-026-02531-1

Keywords: SARS-CoV-2, COVID-19, oxysterols, 25-hydroxycholesterol, aging, cholesterol metabolism, intestine, lipidomics, Syrian hamster, gut-lung axis, innate immunity, GeroScience

7-ketocholesterol is one of the most abundant cholesterol oxidation products in the human body. It arises when free cholesterol encounters oxidative stress, a condition in which reactive oxygen species overwhelm cellular antioxidant defenses. Because pregnancy itself is a state of controlled oxidative stress, and because conditions such as preeclampsia, gestational diabetes, and maternal hypercholesterolemia amplify that stress dramatically, the placenta represents a uniquely vulnerable environment for oxysterol accumulation. The review synthesizes evidence on where 7-ketocholesterol comes from, how it travels through the placenta, and what it does once it arrives.

The sources of this molecule are more varied than many clinicians realize. Endogenously, 7-ketocholesterol forms whenever cholesterol-rich membranes and lipoproteins are exposed to oxidative attack, which can happen in the maternal circulation, in placental tissue, and even in the fetal compartment. Exogenously, it enters the body through the diet: cholesterol-containing foods such as processed meats, eggs, and dairy products generate cholesterol oxidation products during cooking, storage, and reheating, and these dietary oxysterols are readily absorbed. Maternal hypercholesterolemia raises the substrate pool for oxysterol formation, and studies in animal models have shown that mothers with elevated cholesterol carry higher oxysterol concentrations, as do their newly weaned offspring, an effect that can be blunted by maternal phytosterol supplementation.

Once formed, 7-ketocholesterol does not stay put. The placenta is a lipid trafficking hub, actively transferring cholesterol from mother to fetus to support the enormous demands of fetal growth, membrane synthesis, and steroid hormone production. This transfer relies on a coordinated cast of transporters and enzymes, including ABCA1 and ABCG1, which efflux cholesterol from trophoblasts, and placental endothelial cells that deliver cholesterol efficiently into the fetal circulation. The critical question raised by the review is whether oxidized cholesterol derivatives piggyback on these same pathways. If 7-ketocholesterol crosses the placental barrier alongside native cholesterol, it could expose fetal tissues to a molecule known to be cytotoxic at relatively low concentrations.

What happens when trophoblasts, the workhorse cells of the placenta, encounter oxysterols? Experimental work offers troubling clues. Studies of term primary trophoblasts have shown that oxysterols inhibit the differentiation and fusion of these cells by activating liver X receptors, a family of nuclear receptors that regulate lipid metabolism. Trophoblast fusion is essential for forming the syncytiotrophoblast, the multinucleated layer that performs nutrient exchange and hormone secretion, so any interference with this process could compromise placental capacity. Oxysterols also exert proinflammatory effects in trophoblasts through Toll-like receptor 4-dependent, cholesterol-sensitive activation of NF-κB, igniting inflammatory signaling cascades within the very cells that anchor the pregnancy.

The cellular damage does not stop there. 7-ketocholesterol is notorious for disrupting mitochondrial function, promoting lysosomal dysfunction, and triggering autophagic markers such as light chain 3 processing and protein ubiquitination in vascular cells. Its polar chemical nature means it lodges preferentially within membrane domains, including lipid rafts, altering membrane order and biophysical properties in ways that can flip cellular signaling from survival toward death. In fetoplacental endothelial cells, oxysterol exposure induces inflammatory responses and dysfunction, although activation of liver X receptors has been shown to attenuate some of this damage, hinting at a possible therapeutic lever. Placental ABCA1 and ABCG1 transporters appear to protect trophoblasts by effluxing cholesterol and oxysterols, and increased cholesterol efflux capacity has been observed in preeclampsia, possibly reflecting a compensatory response to lipid stress.

Metabolism of 7-ketocholesterol is another piece of the puzzle. Outside the liver, the molecule is handled by esterification to fatty acids via the enzymes cPLA2α and SOAT1, followed by selective efflux to high-density lipoprotein. Whether the placenta possesses sufficient capacity to detoxify 7-ketocholesterol by these routes remains an open question, and the review highlights this as a key knowledge gap. Enzymes such as placental CYP27A1, which is upregulated in preeclampsia, may also participate in oxysterol handling, suggesting that the placenta actively attempts to manage oxidized sterols even under pathological conditions.

The most provocative framing in the review connects 7-ketocholesterol to the Developmental Origins of Health and Disease, or DOHaD, framework. This paradigm holds that adverse conditions in the womb, from poor nutrition to oxidative stress, can program lasting changes in offspring metabolism, cardiovascular function, and disease risk. Oxidative stress is known to drive epigenetic modifications, including DNA methylation changes, and early pregnancy dyslipidemia has been associated with placental DNA methylation at loci relevant to cardiometabolic disease. If 7-ketocholesterol contributes to the oxidative and inflammatory milieu of a stressed placenta, it could serve as a concrete molecular mediator linking maternal lipid disturbances to fetal programming, potentially influencing offspring risks ranging from obesity and metabolic syndrome to neurodevelopmental conditions.

Epidemiological signals lend circumstantial support to this idea. Maternal cholesterol levels have been linked in birth cohort studies to offspring attention deficit hyperactivity disorder, with apparent sex differences, and maternal metabolic profiles in early pregnancy correlate with offspring adiposity in childhood. Maternal intrahepatic cholestasis of pregnancy, a disorder of bile acid and lipid handling, has been associated with neurodevelopmental conditions in a population-based cohort of two million Swedish children. A pilot study has even reported associations between maternal mid-pregnancy cholesterol and oxysterol concentrations and labor duration. None of these findings proves causation for 7-ketocholesterol specifically, but together they sketch a pattern in which maternal lipid biology leaves measurable fingerprints on fetal development.

The authors are careful to frame their work as a call to arms rather than a settled verdict. Direct measurements of 7-ketocholesterol in human placental tissue, cord blood, and fetal circulation remain scarce, and much of the mechanistic evidence comes from cell culture and animal studies using related oxysterols. Analytical challenges, including the instability of oxysterols and the technical demands of mass spectrometry-based measurement, have likely slowed progress. The review points toward several priorities: quantifying 7-ketocholesterol across normal and complicated pregnancies, mapping its placental transport and metabolism, testing whether dietary and antioxidant interventions can lower maternal oxysterol burden, and exploring whether liver X receptor activation or other protective pathways can shield the fetoplacental unit. If future studies confirm the review’s central hypothesis, a molecule forged from ordinary cholesterol by ordinary oxidative wear could become an unexpected target for protecting both pregnancies and the lifelong health of the children they produce.

Subject of Research: The role of the oxysterol 7-ketocholesterol in placental pathophysiology, fetal programming, and long-term offspring health

Article Title: The Role of 7-ketocholesterol in Placental Pathophysiology: Implications for Fetal Programming and Long-term Health: A Narrative Review

Article References: Ganamurali, N., & Sabarathinam, S. (2026). The Role of 7-ketocholesterol in Placental Pathophysiology: Implications for Fetal Programming and Long-term Health: A Narrative Review. Reproductive Sciences. https://doi.org/10.1007/s43032-026-02207-3

Image Credits: AI Generated

DOI: 10.1007/s43032-026-02207-3

Keywords: 7-ketocholesterol, placenta, oxysterols, oxidative stress, fetal programming, pregnancy, trophoblast, cholesterol transport, epigenetics, DOHaD, preeclampsia, maternal hypercholesterolemia